Related Experiment Video
Updated: Aug 15, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
[Intraocular metastatic renal carcinoma presenting as progressive unilateral blindness]
J A Gómez Pascual1, M S Martínez Martín, R Bonilla Parrilla
1Servicio de Urología, Hospital Regional de Málaga, Complejo Hospitalario Carlos Haya, Málaga.
Abstract:
Clear cell renal carcinoma is the most common histological type, representing 70-80% of all renal carcinomas. Metastases are already present in about 25-30% of patients at the time of diagnosis of renal cell carcinoma. Ocular metastasis is extremely rare.
Insights
Clear cell renal carcinoma, the most common kidney cancer, frequently metastasizes. Ocular metastasis, a rare complication, presents a diagnostic challenge in renal cell carcinoma patients.
Area of Science:
- Oncology
- Ophthalmology
- Pathology
Background:
- Clear cell renal carcinoma (CCRC) is the predominant histological subtype of kidney cancer, accounting for 70-80% of all cases.
- Metastatic disease is a significant concern, with 25-30% of CCRC patients presenting with metastases at initial diagnosis.
Observation:
- Ocular metastasis, while exceedingly uncommon, represents a rare but serious manifestation of advanced renal cell carcinoma.
- This abstract highlights the rarity of ocular involvement in the context of widespread CCRC metastasis.
Findings:
- The study underscores the low incidence of ocular metastases in patients diagnosed with renal cell carcinoma.
- Despite the high prevalence of CCRC and its metastatic potential, the eyes are an infrequent site of secondary involvement.
Implications:
- Early detection and management of CCRC metastases are crucial for patient outcomes.
- The extreme rarity of ocular metastasis necessitates a high index of suspicion in specific clinical scenarios involving CCRC patients with unexplained visual symptoms.
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment

